You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • OP0155 Ustekinumab Effectively Reduces Active Inflammation as Detected by Magnetic Resonance Imaging in Patients with Active Ankylosing Spondylitis: Results of A 28-Week, Prospective, Open-Label, Proof-Of-Concept Study (TOPAS)

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Oral Presentations. Abstract session: Treatment of spondyloarthritis: moving forward
OP0155 Ustekinumab Effectively Reduces Active Inflammation as Detected by Magnetic Resonance Imaging in Patients with Active Ankylosing Spondylitis: Results of A 28-Week, Prospective, Open-Label, Proof-Of-Concept Study (TOPAS)

 

Online download statistics by month:

Online download statistics by month: June 2014 to December 2023

AbstractFullPdf
Jun 20144201
Jul 20141800
Aug 20141902
Sep 20141700
Oct 20142001
Nov 20141402
Dec 20142103
Jan 2015400
Feb 2015601
Mar 2015501
Apr 2015600
May 2015100
Jun 20151200
Jul 20151800
Aug 2015900
Sep 2015600
Oct 2015400
Nov 20151701
Dec 20151304
Jan 2016900
Feb 20161202
Mar 2016800
Apr 20161202
May 20161000
Jun 2016800
Jul 20161201
Aug 2016400
Sep 2016900
Oct 20161201
Nov 20165023
Dec 20161201
Jan 20171100
Feb 2017900
Mar 2017701
Apr 2017400
May 20171200
Jun 2017901
Jul 20171100
Aug 20172000
Sep 2017801
Oct 2017800
Nov 20171400
Dec 20172400
Jan 20181202
Feb 20181403
Mar 20181200
Apr 20181200
May 20182000
Jun 2018600
Jul 2018800
Aug 2018600
Sep 20181801
Oct 2018400
Nov 2018200
Jan 2019600
Feb 2019200
Mar 2019400
Apr 2019601
Jun 2019200
Jul 2019801
Oct 2019401
Dec 2019200
Jan 2020200
Feb 2020200
Mar 2020201
Jul 2020200
Sep 20201001
Oct 2020200
Nov 2020400
Dec 2020400
Jan 20211001
Mar 2021200
Apr 2021200
Jun 2021001
Nov 2021400
Dec 2021400
Jan 2022400
Feb 2022200
Mar 2022800
Apr 2022600
May 2022300
Jun 2022400
Jul 20221600
Aug 2022500
Sep 2022600
Oct 2022600
Nov 2022400
Dec 20221000
Jan 2023200
Feb 2023400
Mar 2023200
Apr 2023200
May 2023400
Jun 2023200
Jul 2023200
Aug 2023200
Sep 2023600
Dec 2023600
Total806062